温氏股份 reported revenue of ¥46.76B for the period ended 2026-06-30, -6.2% year on year. Net income was ¥-4.40B, a -9.4% net margin on a -2.9% gross margin. The largest revenue line is 肉猪类 at 57% of the total. Free cash flow for the period was ¥-4.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥46.76B | -6.2% |
| Gross profit | ¥-1.35B | — |
| Operating income | ¥-4.31B | — |
| Net income | ¥-4.40B | -224.5% |
| Gross margin | -2.9% | Net margin -9.4% |
| Revenue Q/Q | -9.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 肉猪类 | ¥26.65B | 57.0% |
| 肉鸡类 | ¥17.43B | 37.3% |
| 其他养殖类 | ¥1.80B | 3.9% |
| 兽药 | ¥0.35B | 0.7% |
| 肉制品加工产品 | ¥0.29B | 0.6% |
| 工程、设备类 | ¥0.21B | 0.4% |
| 其他 | ¥0.02B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥48.11B | 102.9% |
| R&D | ¥0.40B | 0.8% |
| SG&A | ¥1.88B | 4.0% |
| Tax & other | ¥0.08B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥93.62B |
| Total liabilities | ¥55.18B |
| Shareholders' equity | ¥38.44B |
| Equity / assets | 41.1% |
| Operating cash flow | ¥-0.87B |
| Capital expenditure | ¥3.19B |
| Free cash flow | ¥-4.05B |
| Cash conversion (OCF / net income) | -10% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新易盛 ・ 亿联网络 ・ 圣邦股份 ・ 宁德时代 ・ 迈瑞医疗 ・ 指南针 ・ 新产业 ・ 安克创新 ・ 爱美客 ・ 金龙鱼 ・ 锐捷网络 ・ 软通动力
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies